PIONEERING SONODYNAMIC THERAPY FOR BRAIN CANCER

We are supported by some of the foremost thought leaders in brain cancer, as well as the American Cancer Society (ACS) and the National Brain Tumor Society (NBTS).

About Sonodynamic TherapyAbout Our Clinical Trial

WHY WE DO IT

Glioblastoma (GBM) is one of the most complex, deadly, and treatment-resistant cancers.  Survival rates and mortality statistics for GBM have been virtually unchanged for decades.

27 Americans die every day from Glioblastoma
After 5 years 6.8% survival rate from Brain Cancer Tumor
Only 5 FDA Approved Treatments for Glioblastoma

WHAT WE DO

Alpheus Medical is developing an innovative solution to treat aggressive brain tumors using ultrasound delivered via a non-invasive, proprietary device.

The device uses sonodynamic therapy (SDT), a treatment that uses ultrasound to activate a drug targeting cancer cells.  Alpheus Medical’s proprietary device is applied to the entire diseased hemisphere,  targeting tumor cells you can see and those you can’t.

Glioblastoma is a diffuse, infiltrative disease with tumor cells invading far beyond the borders of the visible tumor. Even with a complete resection, we know that only part of the tumor has been addressed. This is a disease that requires more than just a focal therapy.  

Alpheus Medical is developing a technology to address this problem by targeting tumor cells beyond the borders of the tumor via a non-invasive procedure.  During the procedure, the patient is awake and is able to go home the same day.  No imaging, such as MRI, is required during the treatment.

This investigational treatment represents a paradigm shift in the way patients with brain tumors are treated.

HOW WE DO IT

The patient drinks a drug that is already FDA approved for use in brain tumor surgery

Alpheus Medical Sonondynamic Therapy: Patient drinks an FDA approved drug

The drug accumulates inside brain cancer cells but not in healthy cells

blank

Once the tumor cells are loaded with drug molecules, ultrasound is non-invasively delivered to the brain by a novel device

Ultrasound is non-invasively delivered to the brain by a novel device

 When the ultrasound hits the drug molecules they release a form of oxygen (called an oxygen radical) in the cancerous cells, causing cell death

Oxygen radicals released by the drug cause cancerous cell death

Finally, the immune system eliminates the broken-down cancer cells from the body

blank

HELP US COMBAT GBM

THE SONODYNAMIC BRAIN CANCER TRIAL

Researching a NEW & NOVEL option for patients

The sonodynamic therapy brain cancer clinical trial will soon be recruiting patients in the United States.  The trial is designed to investigate the safety and feasibility of the treatment.

For more information please contact info@alpheusmedical.com

 

ABOUT ALPHEUS MEDICAL

Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, developing a novel sonodynamic therapy platform targeting solid body cancers. The company’s lead product utilizes a novel, non-invasive drug device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM). Alpheus Medical’s work has been developed in conjunction with some of the most accomplished names worldwide in neuro-oncology, and with support from the American Cancer Society and National Brain Tumor Society.

Biotechnology laboratory
Alpheus Medical Team Meeting Facility
Corporate facility at Alpheus Medical
Alpheus Medical Headquarters at Incubology
Alpheus Medical at 3510 Hopkins Place, North Oakdale

CORPORATE

Alpheus Medical, Inc.
3510 Hopkins Place
North Oakdale MN 55128

info@alpheusmedical.com

© 2021 Alpheus Medical Inc., All Rights Reserved. | CAUTION: Investigational device in the United States. Limited by Federal law to investigational use.